Grant: Doctoral: Vanier Canada Graduate Scholarships
University of Toronto
$50,000.00
The Role of Epidermal Growth Factor-Like domain 7 and Immunosuppressive Strategies in Attenuating Transplant Related Vascular Injury
EF 2008-09
Résumé
Today, a heart transplant is the best available option for patients with end-stage heart failure. Successful research has improved patient survival following heart transplants. However, many problems with heart transplants still happen both in the short and long term. Over 45% of patients receiving a heart transplant develop coronary artery disease (CAD) or narrowing of the heart arteries. This CAD happens as early as three years following surgery and severely limits long term survival of transplant patients. Injury to the new heart's blood vessels at the time of surgery has been suggested to be an important factor in the development of CAD. Furthermore, many common anti-rejection drugs cause damage to the blood vessels in the heart. We think that new ways of protecting arteries (both in the heart and elsewhere in the body) will reduce many of the complications that happen after a heart transplant. This project proposes to determine the best way of protecting the heart arteries after heart transplantation by (1) examining a new target that may protect blood vessels and (2) testing different combinations of vascular protective medications and anti-rejection drugs in a mouse model of vascular disease. In this manner we hope to tailor vascular protective therapy for heart transplant patients to greatly improve their survival.
Programme
Doctoral: Vanier Canada Graduate Scholarships
Bénéficiaire
Emplacement
Ontario, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database
Tel que publié
Id
184570
Name
Badiwala Mitesh V
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Circulatory and Respiratory Health
Theme2
Biomedical
Prcname2
Doctoral Research Awards - A
Projecttitle
The Role of Epidermal Growth Factor-Like domain 7 and Immunosuppressive Strategies in Attenuating Transplant Related Vascular Injury
Programtype2
Studentship Programs
Orgnameinp2
University of Toronto
Cihramount2
$50,000
Cihrequipment2
$0
Programname2
Doctoral: Vanier Canada Graduate Scholarships
Keyworddelim
Endothelium; Immunosuppression; Inflammation; Neointimal Hyperplasia; Transplant Vasculopathy
Abstract
Today, a heart transplant is the best available option for patients with end-stage heart failure. Successful research has improved patient survival following heart transplants. However, many problems with heart transplants still happen both in the short and long term. Over 45% of patients receiving a heart transplant develop coronary artery disease (CAD) or narrowing of the heart arteries. This CAD happens as early as three years following surgery and severely limits long term survival of transplant patients. Injury to the new heart's blood vessels at the time of surgery has been suggested to be an important factor in the development of CAD. Furthermore, many common anti-rejection drugs cause damage to the blood vessels in the heart. We think that new ways of protecting arteries (both in the heart and elsewhere in the body) will reduce many of the complications that happen after a heart transplant. This project proposes to determine the best way of protecting the heart arteries after heart transplantation by (1) examining a new target that may protect blood vessels and (2) testing different combinations of vascular protective medications and anti-rejection drugs in a mouse model of vascular disease. In this manner we hope to tailor vascular protective therapy for heart transplant patients to greatly improve their survival.
Competitiondate
200811
Approvedterm2
1 yr 0 mth
Pinamesdelim
Badiwala, Mitesh V
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $50,000~ $0~